Reni Benjamin of Raymond James maintains a Strong Buy rating on TG Therapeutics Inc (NASDAQ: TGTX) after hosting an investor meeting with Charles Farber, a notable physician at the Summit Medical Group.
Latest Ratings for TGTX
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Mar 2017 | H.C. Wainwright | Reiterates | Buy | |
| Feb 2017 | Aegis Capital | Initiates Coverage On | Buy | |
| Oct 2016 | Brean Capital | Assumes | Buy |
View More Analyst Ratings for TGTX
View the Latest Analyst Ratings
April 21, 2017 at 08:00PM
from Jayson Derrick
No comments:
Post a Comment